Top 20 of Coronary Disease

Article title # Publications/# Citations

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

2001: Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults;

2385

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

2002: National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);

1513

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

2002: Writing Group for the Women's Health Initiative Investigators; GLAnderson; SABeresford; BVHoward; RDJackson; KCJohnson; CKooperberg; JMKotchen; ... AZLaCroix; JOckene; RLPrentice; JERossouw; MLStefanick;

1331

Prediction of coronary heart disease using risk factor categories.

1998: AMBélanger; RBD'Agostino; WBKannel; DLevy; HSilbershatz; PWWilson;

958

Optical coherence tomography.

1991: WChang; TFlotte; KGregory; MRHee; DHuang; CPLin; CAPuliafito; JSSchuman; WGStinson; EASwanson;

808

Banting lecture 1988. Role of insulin resistance in human disease.

1988: GMReaven;

803

Inflammation, atherosclerosis, and coronary artery disease.

2005: GKHansson;

723

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

1989:

662

The Cardiovascular Health Study: design and rationale.

1991: NOBorhani; PEnright; LPFried; CDFurberg; JMGardin; RAKronmal; LHKuller; TAManolio; MBMittelmark; ANewman;

611

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

2002: Heart Protection Study Collaborative Group;

588

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

1998: SMHaffner; MLaakso; SLehto; KPyörälä; TRönnemaa;

532

Quantification of coronary artery calcium using ultrafast computed tomography.

1990: ASAgatston; RDetrano; FJHildner; WRJanowitz; MViamonte; NRZusmer;

532

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

2005: Cholesterol Treatment Trialists' (CTT) Collaborators; CBaigent; LBlackwell; GBuck; RCollins; PMKearney; AKeech; AKirby; ... RPeto; CPollicino; RSimes; TSourjina;

531

Atherosclerosis.

2000: AJLusis;

488

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

1995: SMCobbe; IFord; CGIsles; ARLorimer; PWMacfarlane; JHMcKillop; CJPackard; JShepherd;

483

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

1989: TECarew; JCKhoo; SParthasarathy; DSteinberg; JLWitztum;

468

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

2004: Women's Health Initiative Steering Committee; GLAnderson; ARAssaf; TBassford; SABeresford; HBlack; DBonds; RBrunner; ... RBrzyski; BCaan; RChlebowski; DCurb; MGass; JHays; GHeiss; SHendrix; BVHoward; JHsia; AHubbell; RJackson; KCJohnson; HJudd; JMKotchen; LKuller; AZLaCroix; DLane; RDLanger; NLasser; CELewis; MLimacher; JManson; KMargolis; MJO'Sullivan; JOckene; LPhillips; RLPrentice; CRitenbaugh; JRobbins; JERossouw; GSarto; MLStefanick; LVan Horn; JWactawski-Wende; RWallace; SWassertheil-Smoller;

463

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

1996: JMArnold; EBraunwald; LBrown; TGCole; BRDavis; LAMoyé; MAPfeffer; JLRouleau; ... JDRutherford; FMSacks; JWWarnica; CCWun;

450

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

2002: EKumpusalo; DELaaksonen; HMLakka; TALakka; LKNiskanen; JTSalonen; JTuomilehto;

437

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

1998:

423